DocDollars

Janssen Biotech, Inc.

PA · United States · Reporting entity ID 100000000329

Total reported 2019–2025
$141.1M
#73 of 2,960 reporting companies — 0.2% of all reported industry payments
$127.1M in general payments across 1,540,685 records, plus $14.0M in research funding across 21 records.

How it breaks down

General payments $127,099,310
Research funding $14,013,484

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Janssen Biotech, Inc. reported $141.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #73 of 2,960 reporting companies. 10% of that was research funding and 90% general payments such as consulting, speaking, food and travel. 1,540,685 general payment records and 21 research records were filed.

Common questions about Janssen Biotech, Inc.

How much has Janssen Biotech, Inc. paid US doctors?

Janssen Biotech, Inc. reported $141,112,793 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $127,099,310 in general payments, $14,013,484 in research funding.

How does Janssen Biotech, Inc. rank among drug and device companies?

It ranks #73 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Janssen Biotech, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.